• Trump announced a 100% tariff on imported branded or patented pharmaceuticals starting October 1—unless companies are building U.S. production facilities. 

• The tariff won’t apply to the EU and Japan, according to the White House, likely due to existing agreements capping rates. 

• Pharma stocks slid globally on the news—companies scrambling to shore up U.S. presence may avoid the blow, but uncertainty reigns.